Brief: Abionyx Pharma FY Total Revenue At 0.67 Million Euros

Abionyx Pharma SA

24/02/2022 17:18

Feb 24 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA PROVIDES AN UPDATE ON ITS BUSINESS AND CASH
POSITION FOR Q4 2021
    * CONSOLIDATED REVENUE IN 2021 INCLUDING FIRST MONTH OF
ACTIVITY
FROM IRIS PHARMA: EUR 675K
    * CASH POSITION OF EUR 7.9 MILLION AS OF DECEMBER 31, 2021

Source text for Eikon:  ID:nBw8hh4MGa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))